Key facts
- Notable investors include Guoyao Venture Capital, Binhu State-owned Capital Operation Holding Group.
- Status: Privately Held (backing).
- ·The complete investor list — 2 names
- ·Watchlist + deal alerts for Yilianlitong
- ·The full record, as it builds
Funding rounds
No funding rounds for Yilianlitong are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Yilianlitong
Manufacturers of minimally invasive medical devices intended to serve prostate disease. The company offers research and development of the suspension treatment, a minimally invasive method between medication and surgical removal, thereby providing patients with a potential treatment.
- Sector
- Healthcare
- HQ
- Hefei, China
- Founded
- 2024
- Website
- elionmedlink.com/
- Ownership
- Privately Held (backing)
Yilianlitong doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Yilianlitong shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Yilianlitong in its N-PORT filings yet. We sweep new filings monthly.